Skip to main content
Top
Published in: Diabetologia 3/2011

01-03-2011 | Short Communication

Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth

Authors: D. Dabelea, L. M. Dolan, R. D’Agostino Jr, A. M. Hernandez, J. B. McAteer, R. F. Hamman, E. J. Mayer-Davis, S. Marcovina, J. M. Lawrence, C. Pihoker, J. C. Florez

Published in: Diabetologia | Issue 3/2011

Login to get access

Abstract

Aim/hypothesis

Common variants in the transcription factor 7-like 2 (TCF7L2) gene have been associated with type 2 diabetes in adults. However, it is not known whether TCF7L2 variation increases the risk of early onset type 2 diabetes. Using a case–control design, we examined whether the reported variants [rs12255372 (T/G) and rs7903146 (T/C)] are associated with type 2 diabetes in SEARCH for Diabetes in Youth study participants.

Methods

Variants were genotyped in 694 non-Hispanic white (NHW) youth (86 cases, mean age 15.5 years, mean BMI 34.8; and 608 controls, mean age 14.4 years, mean BMI 22.3) and 545 African-American (AA) youth (154 cases, mean age 15.9, mean BMI 37; and 391 controls, mean age 14.8, mean BMI 23.8). Logistic regression adjusted for age, sex, BMI and West African ancestry.

Results

The association of the risk T allele with case/control status was different in AA and NHW youth (p = 0.025). Among AA youth, each copy of the T allele (rs7903146) was associated with a 1.97-fold (1.37, 2.82) increased odds for type 2 diabetes (p < 0.0001), after adjustment for age, sex, BMI and African ancestry. No significant association was detected in NHW youth (adjusted OR, 1.14; 0.73, 1.79).

Conclusion/interpretation

TCF7L2 variation is associated with an increased risk of early-onset type 2 diabetes among AA youth, and the association appears to be stronger in AA than NHW youth. This suggests potential different contributions of genetic and environmental factors to early-onset type 2 diabetes by race.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Cauchi S, El Achhab Y, Choquet H et al (2007) TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med 85:777–782CrossRefPubMed Cauchi S, El Achhab Y, Choquet H et al (2007) TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med 85:777–782CrossRefPubMed
3.
go back to reference Dabelea D, Bell RA, D'Agostino RB Jr et al (2007) Incidence of diabetes in youth in the United States. JAMA 297:2716–2724CrossRefPubMed Dabelea D, Bell RA, D'Agostino RB Jr et al (2007) Incidence of diabetes in youth in the United States. JAMA 297:2716–2724CrossRefPubMed
4.
go back to reference Dabelea D, Mayer-Davis EJ, Lamichhane AP et al (2008) Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH case-control study. Diab Care 31:1422–1426CrossRef Dabelea D, Mayer-Davis EJ, Lamichhane AP et al (2008) Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH case-control study. Diab Care 31:1422–1426CrossRef
5.
go back to reference Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
6.
go back to reference Tang K, Fu DJ, Julien D et al (1999) Chip-based genotyping by mass spectrometry. Proc Natl Acad Sci USA 96:10016–10020CrossRefPubMed Tang K, Fu DJ, Julien D et al (1999) Chip-based genotyping by mass spectrometry. Proc Natl Acad Sci USA 96:10016–10020CrossRefPubMed
7.
go back to reference Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155:945–959PubMed Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155:945–959PubMed
8.
go back to reference Raitakari OT, Ronnemaa T, Huupponen R et al (2007) Variation of the transcription factor 7-like 2 (TCF7L2) gene predicts impaired fasting glucose in healthy young adults: the Cardiovascular Risk in Young Finns Study. Diab Care 30:2299–2301CrossRef Raitakari OT, Ronnemaa T, Huupponen R et al (2007) Variation of the transcription factor 7-like 2 (TCF7L2) gene predicts impaired fasting glucose in healthy young adults: the Cardiovascular Risk in Young Finns Study. Diab Care 30:2299–2301CrossRef
9.
go back to reference Yu J, Steck AK, Babu S et al (2009) Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes. J Clin Endocrinol Metab 94:504–510CrossRefPubMed Yu J, Steck AK, Babu S et al (2009) Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes. J Clin Endocrinol Metab 94:504–510CrossRefPubMed
10.
11.
go back to reference Gaulton KJ, Nammo T, Pasquali L et al (2010) A map of open chromatin in human pancreatic islets. Nat Genet 42:255–259CrossRefPubMed Gaulton KJ, Nammo T, Pasquali L et al (2010) A map of open chromatin in human pancreatic islets. Nat Genet 42:255–259CrossRefPubMed
Metadata
Title
Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth
Authors
D. Dabelea
L. M. Dolan
R. D’Agostino Jr
A. M. Hernandez
J. B. McAteer
R. F. Hamman
E. J. Mayer-Davis
S. Marcovina
J. M. Lawrence
C. Pihoker
J. C. Florez
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 3/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1982-7

Other articles of this Issue 3/2011

Diabetologia 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.